Literature DB >> 15920289

Use of yeast as a model system to investigate protein conformational diseases.

Christina M Coughlan1, Jeffrey L Brodsky.   

Abstract

Protein conformational diseases arise when a cellular protein adopts an aberrant shape that either directly or indirectly alters the physiology of its host cell. Notable conformational diseases include cystic fibrosis, Huntington's disease, the prion-related diseases, Alzheimer's disease, and antitrypsin deficiency. In principle, the severity and progression of conformational diseases can be altered by cellular factors that recognize and attempt to ameliorate the harmful effects of the disease-causing, misshapen protein. To better define the mechanistic underpinnings of cellular factors that mediate quality control, and to understand why a single misfolded protein can impact cell viability, specific proteins that cause each of the diseases listed above have been expressed in a model eukaryote, the yeast Saccharomyces cerevisiae. In this review, we describe what has been learned from these studies, and speculate on future uses of yeast expression systems.

Entities:  

Mesh:

Year:  2005        PMID: 15920289     DOI: 10.1385/MB:30:2:171

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  90 in total

1.  Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion.

Authors:  Y O Chernoff; G P Newnam; J Kumar; K Allen; A D Zink
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.

Authors:  T Jin; Y Gu; G Zanusso; M Sy; A Kumar; M Cohen; P Gambetti; N Singh
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

3.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

5.  Association between calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin.

Authors:  A Le; J L Steiner; G A Ferrell; J C Shaker; R N Sifers
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

6.  Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.

Authors:  R C Rubenstein; P L Zeitlin
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

7.  Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.

Authors:  S Krobitsch; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

9.  Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

Authors:  D M Kovacs; H J Fausett; K J Page; T W Kim; R D Moir; D E Merriam; R D Hollister; O G Hallmark; R Mancini; K M Felsenstein; B T Hyman; R E Tanzi; W Wasco
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

10.  Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Xiangwei He; Gary P Newnam; Yury O Chernoff; Michael Y Sherman
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  10 in total

1.  Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.

Authors:  Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.

Authors:  Aleksandr A Rubel; Tatyana A Ryzhova; Kirill S Antonets; Yury O Chernoff; Alexey Galkin
Journal:  Prion       Date:  2013-10-23       Impact factor: 3.931

3.  Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast.

Authors:  Louis J Sparvero; Sarah Patz; Jeffrey L Brodsky; Christina M Coughlan
Journal:  Anal Biochem       Date:  2007-08-10       Impact factor: 3.365

Review 4.  Cellular strategies for controlling protein aggregation.

Authors:  Jens Tyedmers; Axel Mogk; Bernd Bukau
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10-14       Impact factor: 94.444

5.  Proteasome activity modulates amyloid toxicity.

Authors:  John Galvin; Elizabeth Curran; Francisco Arteaga; Alicia Goossens; Nicki Aubuchon-Endsley; Michael A McMurray; Jeffrey Moore; Kirk C Hansen; Heidi J Chial; Huntington Potter; Jeffrey L Brodsky; Christina M Coughlan
Journal:  FEMS Yeast Res       Date:  2022-03-09       Impact factor: 2.796

6.  Improving recombinant protein production by yeast through genome-scale modeling using proteome constraints.

Authors:  Yu Chen; Qi Qi; Yanyan Wang; Feiran Li; Le Yuan; Mingtao Huang; Ibrahim E Elsemman; Amir Feizi; Eduard J Kerkhoven; Jens Nielsen
Journal:  Nat Commun       Date:  2022-05-27       Impact factor: 17.694

7.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

8.  Hsp90-Associated Immunophilin Homolog Cpr7 Is Required for the Mitotic Stability of [URE3] Prion in Saccharomyces cerevisiae.

Authors:  Navinder Kumar; Deepika Gaur; Arpit Gupta; Anuradhika Puri; Deepak Sharma
Journal:  PLoS Genet       Date:  2015-10-16       Impact factor: 5.917

Review 9.  Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.

Authors:  Sebastian Hofer; Katharina Kainz; Andreas Zimmermann; Maria A Bauer; Tobias Pendl; Michael Poglitsch; Frank Madeo; Didac Carmona-Gutierrez
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 6.261

10.  Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease.

Authors:  Daniel W Neef; Michelle L Turski; Dennis J Thiele
Journal:  PLoS Biol       Date:  2010-01-19       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.